help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, M. F.
Right arrow Articles by Schimmer, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, M. F.
Right arrow Articles by Schimmer, B. P.

Molecular Endocrinology, Vol 7, 477-487, Copyright © 1993 by Endocrine Society


ARTICLES

Molecular basis for the 3',5'-cyclic adenosine monophosphate resistance of Kin mutant Y1 adrenocortical tumor cells

MF Olson, AJ Krolczyk, KB Gorman, RA Steinberg and BP Schimmer
Banting and Best Department of Medical Research, University of Toronto, Ontario, Canada.

A series of mutant cell lines (Kin) were previously isolated from Y1 adrenocortical tumor cells based on their ability to resist the growth- inhibitory effects of 8-bromo cAMP. In these Kin clones, cAMP-dependent protein kinase (cAMPdPK) was resistant to activation by cAMP as the consequence of mutations affecting the type I regulatory subunit (RI) of the enzyme. This study shows that the cAMP-resistant phenotypes of mutant clones Kin-2, Kin-7, and Kin-8 were associated with single base changes causing substitutions, respectively, of Glu for Gly200, Trp for Arg334, and Asp for Gly324 in the RI protein. By expressing the mutant Trp334 and Asp324 forms of RI under the control of an inducible promoter in Y1 cells, the causal relationship between these RI mutations and impairment of cAMP-stimulated adrenocortical responses was studied. Expression of the mutant RI forms rendered cAMPdPK resistant to activation by cAMP and decreased cAMP-stimulated cell rounding, steroid production, and growth inhibition. These observations indicate that the cAMP-resistant phenotype of Kin mutant clones resulted specifically from single mutational events in RI and thus establish the importance of cAMPdPK as an essential regulator of adrenocortical function. Unlike the original Kin mutant clones, transformants expressing the mutant forms of RI had adenylyl cyclases that were resistant to activation by ACTH, forskolin, or sodium fluoride. These results indicate that there may be a hitherto unappreciated mechanism of regulation of adenylyl cyclase activity by cAMPdPK.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
A. Hoeflich and M. Bielohuby
Mechanisms of adrenal gland growth: signal integration by extracellular signal regulated kinases1/2
J. Mol. Endocrinol., March 1, 2009; 42(3): 191 - 203.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Meoli, I. Bossis, L. Cazabat, M. Mavrakis, A. Horvath, S. Stergiopoulos, M. L. Shiferaw, G. Fumey, K. Perlemoine, M. Muchow, et al.
Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors
Cancer Res., May 1, 2008; 68(9): 3133 - 3141.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. P. Schimmer, M. Cordova, H. Cheng, A. Tsao, A. B. Goryachev, A. D. Schimmer, and Q. Morris
Global Profiles of Gene Expression Induced by Adrenocorticotropin in Y1 Mouse Adrenal Cells
Endocrinology, May 1, 2006; 147(5): 2357 - 2367.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A. P. Lepique, M. S Moraes, K. M Rocha, C. B Eichler, G. N M Hajj, T. T Schwindt, and H. A Armelin
c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells
J. Mol. Endocrinol., December 1, 2004; 33(3): 623 - 638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Takemori, Y. Katoh, N. Horike, J. Doi, and M. Okamoto
ACTH-induced Nucleocytoplasmic Translocation of Salt-inducible Kinase. IMPLICATION IN THE PROTEIN KINASE A-ACTIVATED GENE TRANSCRIPTION IN MOUSE ADRENOCORTICAL TUMOR CELLS
J. Biol. Chem., October 25, 2002; 277(44): 42334 - 42343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Doi, H. Takemori, X.-z. Lin, N. Horike, Y. Katoh, and M. Okamoto
Salt-inducible Kinase Represses cAMP-dependent Protein Kinase-mediated Activation of Human Cholesterol Side Chain Cleavage Cytochrome P450 Promoter through the CREB Basic Leucine Zipper Domain
J. Biol. Chem., May 3, 2002; 277(18): 15629 - 15637.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Le and B. P. Schimmer
The Regulation of MAPKs in Y1 Mouse Adrenocortical Tumor Cells
Endocrinology, October 1, 2001; 142(10): 4282 - 4287.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. F. P. Lotfi, Z. Todorovic, H. A. Armelin, and B. P. Schimmer
Unmasking a Growth-promoting Effect of the Adrenocorticotropic Hormone in Y1 Mouse Adrenocortical Tumor Cells
J. Biol. Chem., November 21, 1997; 272(47): 29886 - 29891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Schimmer, J. Tsao, and W. Czerwinski
Amplification of the Transketolase Gene in Desensitization-resistant Mutant Y1 Mouse Adrenocortical Tumor Cells
J. Biol. Chem., March 1, 1996; 271(9): 4993 - 4998.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society